While these results havent been replicated in human trials, a boxed warning exists
I started at the end of November and Im down almost 30 pounds
Am J Physiol Endocrinol Metab 2012;303:E253-64.ArticlePubMed 72
In some cases, EPI can develop after surgical procedures that remove part of the pancreas or affect its function, further complicating the clinical picture
Lilly is studying retatrutide in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes and metabolic dysfunction-associated steatotic liver disease
(NewsNation) As more health benefits of GLP-1 medications are discovered, should everyone consider taking the increasingly popular drugs